↓ Skip to main content

Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies

Overview of attention for article published in Cancer Discovery, November 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#36 of 3,627)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
18 news outlets
blogs
4 blogs
twitter
143 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies
Published in
Cancer Discovery, November 2022
DOI 10.1158/2159-8290.cd-22-0199
Pubmed ID
Authors

Abdullah O. Khan, Antonio Rodriguez-Romera, Jasmeet S. Reyat, Aude-Anais Olijnik, Michela Colombo, Guanlin Wang, Wei Xiong Wen, Nikolaos Sousos, Lauren C. Murphy, Beata Grygielska, Gina Perrella, Christopher B. Mahony, Rebecca E. Ling, Natalina E. Elliott, Christina Simoglou Karali, Andrew P. Stone, Samuel Kemble, Emily A. Cutler, Adele K. Fielding, Adam P. Croft, David Bassett, Gowsihan Poologasundarampillai, Anindita Roy, Sarah Gooding, Julie Rayes, Kellie R. Machlus, Bethan Psaila

Twitter Demographics

The data shown below were collected from the profiles of 143 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 31%
Researcher 4 11%
Unspecified 3 8%
Student > Master 3 8%
Professor > Associate Professor 2 6%
Other 5 14%
Unknown 8 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 31%
Medicine and Dentistry 6 17%
Unspecified 3 8%
Agricultural and Biological Sciences 2 6%
Immunology and Microbiology 2 6%
Other 2 6%
Unknown 10 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 237. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2022.
All research outputs
#128,071
of 22,610,790 outputs
Outputs from Cancer Discovery
#36
of 3,627 outputs
Outputs of similar age
#3,214
of 324,074 outputs
Outputs of similar age from Cancer Discovery
#1
of 75 outputs
Altmetric has tracked 22,610,790 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,627 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,074 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.